Trading: cruise operator Carnival will party again – here's how to play it
Cruise ship operator Carnival shares are cheap and look poised to recover strongly. Matthew Partridge explains how to play it.
The first time that Covid-19 really came to people’s attention was when the Diamond Princess cruise ship was quarantined in early February after an outbreak that infected 714 people and killed 14. By March most countries, including the US, had either banned or heavily restricted cruise ships.
So it’s no surprise that at one stage in early April shares in Carnival Corporation (NYSE: CCL) had fallen by 80% from their price at the start of the year. Even though they subsequently rallied, doubling over the last five months, they are still over 60% down from their 52-week high at a time when the benchmark S&P 500 continues to make new highs.
The clouds are clearing
Still, there are several reasons to be bullish on Carnival. Loosening restrictions in several countries mean that it has resumed some limited cruises, beginning with a journey around Italian ports earlier this month by its subsidiary Costa Cruises. Carnival’s management hopes that this loosening will continue as more countries become more confident that the virus can be contained through testing and social distancing. While it is almost certain that the US ban on cruise ships will be extended for at least another month when it expires in a fortnight’s time, the cruise lines, including Carnival, are aggressively pushing for a limited re-opening in November.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Moreover, with nine vaccine candidates in final-stage trials, at least one could be approved by the end of the year, which, allowing time for production and rollout, means that most restrictions could be lifted by next summer. While there’s always the worry that the crisis has permanently reduced people’s appetite for sailing around the world, this doesn’t seem to be the case, with companies reporting a few months ago that bookings for 2021 were at similar levels to past years. Magazine surveys also suggest that most people have not been deterred from going on a cruise by this year’s chaos.
Even if business does take a little longer to bounce back than expected, Carnival has plenty of financial leeway because it has been able to raise $12bn to bolster its balance sheet. The valuation also looks very attractive with the company trading at just four times 2019 earnings and a 25% discount to the value of its net assets, despite the fact that between 2015 and 2019 it grew sales by a third. What’s more, in 2016, 2017, 2018 and 2019 it earned a double-digit return on capital invested (a key gauge of profitability), showing that it deployed its resources efficiently.
I therefore suggest that you go long on Carnival at the current price of $16.50 at £200 per $1. Cover your position if it falls below $10. This is a slightly looser stop-loss than normal because of the stock’s volatility; it gives you a potential downside of £1,300.
How my tips have fared
My four long tips have struggled during the past fortnight, with one increasing, one staying the same and two falling. Media group ITV rose from 58p to 65p. Equipment firm United Rentals stayed at $177.
However, energy company Royal Dutch Shell fell from 1,086p to 1,078p. Worst of all, thanks to its decision to offer a rights issue at an unexpectedly low price, airline company International Consolidated Airlines Group (IAG) fell from 206p to 135p. While the stop-losses meant that the position was closed at 140p, this still represents a loss of £990.
My short tips haven’t done particularly well either. Online insurance broker eHealth went up from $63 to $75, while exercise bike manufacturer Peloton appreciated from $76 to $81.
At least electric lorry maker Nikola fell from $40 to $35, despite at one stage surging to $50 after announcing a production deal with General Motors.
Online education provider GSX Techedu climbed from $85 to $91, although since I suggested that you wait until it falls below $70 before shorting it, this shouldn’t have any impact on the overall profits and losses.
Counting the losses on IAG, my long tips are making a net profit of £543, while my short tips are making profits of £867.
The upshot is an overall profit of £1,410, though the sum is exceeded by my losses on closed positions.
I now have four long tips (Carnival, Royal Dutch Shell, United Rentals and ITV) and three short tips (eHealth, Pelton and Nikola).
With the Royal Dutch Shell tip set to reach its six- month anniversary in a week’s time, I am very likely to close it next time unless something dramatic happens to turn its fortunes (and share price) around.
Trading techniques: stocks and rights issues
The turmoil caused by the pandemic has prompted many companies to raise more money. While some have borrowed, or sought help from the government, others, notably International Consolidated Airlines Group (IAG), the owner of British Airways, has launched rights issues.
This means that a company sells additional shares to existing shareholders at a discount. In essence, a rights issue is the opposite of a share buyback (whereby a firm buys its own shares, reducing the number of shares that are outstanding).
In theory rights issues should be neutral for the share price provided companies can use the cash raised efficiently. Even if this is not the case, they could still be a sensible move if the only other options are either bankruptcy (which would see existing shareholders wiped out) or taking money on less advantageous terms. A government bailout, for instance, could come with considerable interference in operational decisions. However, in reality they are almost always seen as a sign of weakness or desperation. Studies in both the US and UK suggest that rights issues do indeed have a negative effect on short-term share prices.
For example, a 2000 study by Myron Slovin and Marie Suska of Arizona State University, and K.W. Lai of Lingnan University, found that between 1986 and 1994, the shares of UK companies involved in rights issues fell by an average of 1.8% over the two days after the rights issue was announced.
B. Espen Eckbo of Dartmouth and Ronald W. Masulis of Vanderbilt estimated in 1995 that the average two-day impact in the US was even higher, at around
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published
-
Harworth doubles profit as revenue soars – should you buy?
Harworth, a specialist property developer, is well-aligned with government policies, with revenue expected to rise by over 50% this year, and a further 30% the year after.
By Dr Matthew Partridge Published
-
Bitcoin miner Riot Platforms bleeds money – what happens now?
Riot Platforms struggles to make a profit and looks absurdly overvalued. Are troubles brewing?
By Dr Matthew Partridge Published
-
M&S recovery has momentum: will it stick?
After years of decline, M&S seems to have turned a corner. But is this just a “dead cat bounce”?
By Dr Matthew Partridge Published
-
Is Alpha Group a good buy?
Alpha Group helps clients manage risks such as foreign exchange. After being promoted to the London Stock Exchange, does the stock still rally?
By Dr Matthew Partridge Published
-
Vistry sales improve – should you buy into the boom?
Housebuilder Vistry’s unusual business model has fuelled rapid sales growth amid a sluggish private sales market
By Dr Matthew Partridge Published
-
Ocado shares plunge after FTSE 100 demotion
Ocado remains unprofitable and overvalued. Is it time to let go of the online supermarket?
By Dr Matthew Partridge Published
-
Should you invest in Axos Bank?
Axos Financial is highly exposed to America’s commercial-property slump
By Dr Matthew Partridge Published
-
Is PayPal a good stock to buy?
PayPal's revenue growth has accelerated in double digits, but is the success short lived?
By Dr Matthew Partridge Published